These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 32583455)

  • 1. Need for less tight glucose control in early pregnancy after embryogenesis due to high risk of maternal hypoglycaemia in women with pre-existing diabetes can be compensated by good control in late pregnancy.
    Hauffe F; Fauzan R; Schohe AL; Scholle D; Sedlacek L; Scherer KA; Klapp C; Ramsauer B; Henrich W; Schlembach D; Abou-Dakn M; Schaefer-Graf UM
    Diabet Med; 2020 Sep; 37(9):1490-1498. PubMed ID: 32583455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Addition of intermittently scanned continuous glucose monitoring to standard care in a cohort of pregnant women with type 1 diabetes: effect on glycaemic control and pregnancy outcomes.
    Perea V; Picón MJ; Megia A; Goya M; Wägner AM; Vega B; Seguí N; Montañez MD; Vinagre I
    Diabetologia; 2022 Aug; 65(8):1302-1314. PubMed ID: 35546211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin during pregnancy, labour and delivery.
    de Valk HW; Visser GH
    Best Pract Res Clin Obstet Gynaecol; 2011 Feb; 25(1):65-76. PubMed ID: 21186142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rationale, design, and methods for the Medical Optimization and Management of Pregnancies with Overt Type 2 Diabetes (MOMPOD) study.
    Berry DC; Thomas SD; Dorman KF; Ivins AR; de Los Angeles Abreu M; Young L; Boggess K
    BMC Pregnancy Childbirth; 2018 Dec; 18(1):488. PubMed ID: 30541506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous glucose monitoring metrics and pregnancy outcomes in insulin-treated diabetes: A post-hoc analysis of the GlucoMOMS trial.
    Rademaker D; van der Wel AWT; van Eekelen R; Voormolen DN; de Valk HW; Evers IM; Mol BW; Franx A; Siegelaar SE; van Rijn BB; DeVries JH; Painter RC;
    Diabetes Obes Metab; 2023 Dec; 25(12):3798-3806. PubMed ID: 37735847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-World Evidence of Off-Label Use of Commercially Automated Insulin Delivery Systems Compared to Multiple Daily Insulin Injections in Pregnancies Complicated by Type 1 Diabetes.
    Quirós C; Herrera Arranz MT; Amigó J; Wägner AM; Beato-Vibora PI; Azriel-Mira S; Climent E; Soldevila B; Barquiel B; Colomo N; Durán-Martínez M; Corcoy R; Codina M; Díaz-Soto G; Márquez Pardo R; Martínez-Brocca MA; Rebollo Román Á; López-Gallardo G; Cuesta M; García Fernández J; Goya M; Vega Guedes B; Mendoza Mathison LC; Perea V
    Diabetes Technol Ther; 2024 Aug; 26(8):596-606. PubMed ID: 38417014
    [No Abstract]   [Full Text] [Related]  

  • 7. Discrete glucose profiles identified using continuous glucose monitoring data and their association with adverse pregnancy outcomes.
    Battarbee AN; Sauer SM; Sanusi A; Fulcher I
    Am J Obstet Gynecol; 2024 Jul; 231(1):122.e1-122.e9. PubMed ID: 38527606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of glargine in pregnant women with type 1 diabetes mellitus: a case-control study.
    Imbergamo MP; Amato MC; Sciortino G; Gambina M; Accidenti M; Criscimanna A; Giordano C; Galluzzo A
    Clin Ther; 2008 Aug; 30(8):1476-84. PubMed ID: 18803989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different intensities of glycaemic control for pregnant women with pre-existing diabetes.
    Middleton P; Crowther CA; Simmonds L
    Cochrane Database Syst Rev; 2012 Aug; 8(8):CD008540. PubMed ID: 22895976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Real-world data on the Minimed 780G advanced hybrid closed-loop system use during type 1 diabetes pregnancy: One centre observational study.
    Munda A; Kovacic C; Pongrac Barlovic D
    J Diabetes Complications; 2024 Aug; 38(8):108795. PubMed ID: 38878423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Achieving better outcomes in pregnancies complicated by type 1 and type 2 diabetes mellitus.
    Kinsley B
    Clin Ther; 2007; 29 Suppl D():S153-60. PubMed ID: 18191067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poor pregnancy outcome in women with type 1 diabetes is predicted by elevated HbA1c and spikes of high glucose values in the third trimester.
    Damm P; Mersebach H; Råstam J; Kaaja R; Hod M; McCance DR; Mathiesen ER
    J Matern Fetal Neonatal Med; 2014 Jan; 27(2):149-54. PubMed ID: 23687948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycaemic control throughout pregnancy and risk of pre-eclampsia in women with type I diabetes.
    Temple RC; Aldridge V; Stanley K; Murphy HR
    BJOG; 2006 Nov; 113(11):1329-32. PubMed ID: 17004981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Despite treatment, HbA1c ≥ 37 mmol/mol in the first trimester is associated with premature delivery among South Asian women with gestational diabetes mellitus: a retrospective cohort study.
    Punnose J; Malhotra RK; Sukhija K; Rijhwani RM; Choudhary N; Sharma A
    Arch Gynecol Obstet; 2024 Aug; 310(2):863-872. PubMed ID: 38517506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous glucose monitoring parameters in pregnancy-related complications in patients with type 1 diabetes: a retrospective cohort study.
    Sibiak R; Mantaj U; Gutaj P; Zozulińska-Ziółkiewicz D; Wender-Ozegowska E
    Pol Arch Intern Med; 2023 Nov; 133(11):. PubMed ID: 37227218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors associated with maternal hyperglycaemia and neonatal hypoglycaemia after antenatal betamethasone administration in women with diabetes in pregnancy.
    Rowe CW; Rosee P; Sathiakumar A; Ramesh S; Qiao V; Huynh J; Dennien G; Weaver N; Wynne K
    Diabet Med; 2024 Feb; 41(2):e15262. PubMed ID: 38017692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrosomia despite good glycaemic control in Type I diabetic pregnancy; results of a nationwide study in The Netherlands.
    Evers IM; de Valk HW; Mol BW; ter Braak EW; Visser GH
    Diabetologia; 2002 Nov; 45(11):1484-9. PubMed ID: 12436330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycemic control and perinatal outcomes of pregnancies complicated by type 1 diabetes: influence of continuous subcutaneous insulin infusion and lispro insulin.
    Chico A; Saigi I; García-Patterson A; Santos MD; Adelantado JM; Ginovart G; de Leiva A; Corcoy R
    Diabetes Technol Ther; 2010 Dec; 12(12):937-45. PubMed ID: 21128840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycemic control and selected pregnancy outcomes in type 1 diabetes women on continuous subcutaneous insulin infusion and multiple daily injections: the significance of pregnancy planning.
    Cyganek K; Hebda-Szydlo A; Katra B; Skupien J; Klupa T; Janas I; Kaim I; Sieradzki J; Reron A; Malecki MT
    Diabetes Technol Ther; 2010 Jan; 12(1):41-7. PubMed ID: 20082584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is there a difference in pregnancy and glycemic outcome in patients with type 1 diabetes on insulin pump with constant or intermittent glucose monitoring? A pilot study.
    Petrovski G; Dimitrovski C; Bogoev M; Milenkovic T; Ahmeti I; Bitovska I
    Diabetes Technol Ther; 2011 Nov; 13(11):1109-13. PubMed ID: 21751889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.